Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG in Metastatic Solid Tumors
NCT00294476Phase 2Unknown
- Sponsor
- GammaCan International
- Start
- Jul 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of immune globulin in prostate cancer (PCa), colon cancer and melanoma, sponsored by GammaCan International. Primary endpoints: Tumor Response, Time to Progression and 1 more. Status: unknown.
02
Drugs
immune globulin
03
Conditions
prostate cancer (PCa)colon cancermelanoma
Beyond the preview
Go deeper on NCT00294476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00294476.